glp-1 breast cancer A trio of large observational studies reported at the San Antonio Symposium (SABCS) 2025 suggest that receptor agonists may improve outcomes in some women with breast cancer. Two studies glp-1 drugs and breast cancer

If you are not deficient and are taking it as a supportive measure, you might not feel any dramatic change, and thats okay

Its something Wes Turner, the runner from Charlotte, has thought about, and his answer is in the numbers

Schedule your FREE discovery call today

How Hims is making GLP1 weight loss more accessible for men Hims offers access to several weight loss treatment options, which may be available depending on your individual health background and needs

Accumulating evidence support the existence of a thyroid-gut axis and displays important correlations between the composition of the gut bacteria and thyroid function

That documentation is why our lab keeps reordering